Get started
Author

Moses Kibirige

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
2022 · Thomas L. Holland, Adit A. Ginde, et al. · The Lancet Respiratory Medicine · 123
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15
PDF
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4
PDF
Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial
2022 · Thomas L. Holland, Adit A. Ginde, et al. · SSRN Electronic Journal · 3
Vitamin B12 deficiency presenting as progressive blindness in a 33-year-old HIV-positive female patient on Efavirenz-based regimen: case report
2024 · Gloria Lubega, Joseph Lutaakome, et al. · Pan African Medical Journal · 2
Persistent gaps in the prevention of mother-to-child HIV transmission in central Uganda: a case-control study
2026 · Gloria Lubega, Benard Kikaire, et al. · International Health · 1
Works count: 8
Citation count: 239
H-index: 4
I10-index: 4
Year
Topic
Type